Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 12576 - 12600 of 12870 in total
Name Weight StructureDescriptionCategories
Umirolimus986.294

C55H87NO14
Not AnnotatedAnti-Inflammatory Agents / Immunosuppressive Agents
Carbetocin988.161

C45H69N11O12S
An oxytocin agent used to control postpartum hemorrhage and bleeding after giving birth.Oxytocin and Analogues
Rose bengal I-131989.67

C20H4Cl4I4O5
Not AnnotatedRadiopharmaceuticals
Ridaforolimus990.222

C53H84NO14P
Investigated for use/treatment in solid tumors, sarcoma, cancer/tumors (unspecified), endometrial cancer, prostate cancer, and bone metastases.Mammalian target of rapamycin (mTOR) kinase inhibitors / Protein Kinase Inhibitors
bis(molybdopterin)tungsten cofactor990.77

C20H20MgN10O12P2S4W
Not AvailableNot Available
S-(2-oxo)pentadecylcoa991.916

C36H64N7O17P3S
Not AvailableNot Available
Demoxytocin992.18

C43H65N11O12S2
Not AnnotatedOxytocin and Analogues
Gantacurium993.58

C53H69ClN2O14
Investigated for use/treatment in anesthesia (unspecified).Anticholinergic Agents / Central Nervous System Depressants / Heterocyclic Compounds, Fused-Ring / Muscle Relaxants / Muscle Relaxants, Peripherally Acting Agents / Nicotinic Antagonists
Atosiban994.19

C43H67N11O12S2
An inhibitor of oxytocin and vasopressin used to delay imminent preterm birth in pregnant adult women displaying specific clinical observations.Hormone Antagonists / Tocolytic Agents
ABT-510994.2317

C46H83N13O11
Investigated for use/treatment in lymphoma (unspecified), melanoma, and solid tumors.Amino Acids, Peptides, and Proteins / Peptides
5-Mercaptoethanol-2-decenoyl-coenzyme A994.877

C33H55N7O18P3S2
Not AvailableNot Available
Odalasvir1001.286

C60H72N8O6
Odalasvir has been used in trials studying the treatment of Hepatitis C, Chronic and Chronic Hepatitis C Infection.Antiviral Agents
Gadofosveset trisodium1003.85

C33H38GdN3Na5O14P
An intravenous contrast agent used during magnetic resonance angiography (MRA) to evaluate aortoiliac occlusive disease (AIOD) in adults with peripheral vascular disease.Paramagnetic Contrast Media
Calyculin A1009.185

C50H81N4O15P
Not AvailableCarcinogens / Enzyme Inhibitors / Phosphoprotein Phosphatases, antagonists & inhibitors / Vasoconstrictor Agents
CoA-S-trimethylene-acetyl-tryptamine1009.85

C36H54N9O17P3S
Not AvailableNot Available
Gallium Ga-68 gozetotide1011.909

C44H59GaN6O17
A radiopharmaceutical agent used in the diagnosis of prostate-specific membrane antigen (PSMA) positive lesions in male patients during positron emission tomography.Gallium Radioisotopes / Radioactive Diagnostic Agent / Radiopharmaceuticals
Quinupristin1022.23

C53H67N9O10S
An antibiotic agent used in the treatment of serious vancomycin-resistant Enterococcus faecium bacteremia as well as complicated skin and skin structure infections.Anti-Bacterial Agents / Streptogramin Antibacterial
ILS-9201023.315

C57H86N2O14
ILS-920 is under investigation in clinical trial NCT00827190 (Study Evaluating Single Ascending Doses Of ILS-920).Not Annotated
Flubentylosin1024.227

C53H82FNO17
Not AnnotatedNot Annotated
Mivacurium1029.2608

C58H80N2O14
A short-acting non-depolarizing neuromuscular blocking agent used to induce anesthesia during intubation and promote skeletal muscle relaxation during surgery or mechanical ventilation.Agents producing tachycardia
Temsirolimus1030.2871

C56H87NO16
A antineoplastic agent used in the treatment of renal cell carcinoma (RCC) that works by inhibiting mTOR.Mammalian target of rapamycin (mTOR) kinase inhibitors / Protein Kinase Inhibitors
Lodenafil carbonate1035.21

C47H62N12O11S2
Lodenafil carbonate has been used in trials studying the treatment of Coronaropathy and Erectile Dysfunction.Alkalies / Anions / Carbon Compounds, Inorganic / Carbonic Acid / Electrolytes / Ions
Doxacurium1035.2223

C56H78N2O16
A nondepolarizing neuromuscular blocking agent used as an adjunct to general anesthesia to facilitate tracheal intubation, and to provide skeletal muscle relaxation during surgical procedures.Neuromuscular-Blocking Agents (Nondepolarizing)
Reltecimod1037.2

C46H72N10O15S
Reltecimod is under investigation in clinical trial NCT02469857 (Phase III Efficacy and Safety Study of AB103 in the Treatment of Patients With Necrotizing Soft Tissue Infections).Amino Acids, Peptides, and Proteins / Antigens / Antigens, Differentiation / Antigens, Differentiation, T-Lymphocyte / Antigens, Surface / Biological Factors / Biomarkers / Costimulatory and Inhibitory T-Cell Receptors / Membrane Proteins / Proteins
Thio-Maltohexaose1039.056

C36H62O28S3
Not AvailableNot Available
Displaying drugs 12576 - 12600 of 12870 in total